-
1
-
-
84926609503
-
Geographic variation of intrahepatic cholangiocarcinoma, extrahepatic cholangiocarcinoma, and hepatocellular carcinoma in the United States
-
Altekruse SF, Petrick JL, Rolin AI, Cuccinelli JE, Zou Z, Tatalovich Z, et al. Geographic variation of intrahepatic cholangiocarcinoma, extrahepatic cholangiocarcinoma, and hepatocellular carcinoma in the United States. PloS One 2015;10:e0120574.
-
(2015)
PloS One
, vol.10
-
-
Altekruse, S.F.1
Petrick, J.L.2
Rolin, A.I.3
Cuccinelli, J.E.4
Zou, Z.5
Tatalovich, Z.6
-
2
-
-
84900992727
-
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
-
Bridgewater J, Galle PR, Khan SA, Llovet JM, Park JW, Patel T, et al. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol 2014;60:1268-1289.
-
(2014)
J Hepatol
, vol.60
, pp. 1268-1289
-
-
Bridgewater, J.1
Galle, P.R.2
Khan, S.A.3
Llovet, J.M.4
Park, J.W.5
Patel, T.6
-
4
-
-
79959572626
-
Risk factors for cholangiocarcinoma
-
Tyson GL, El-Serag HB. Risk factors for cholangiocarcinoma. Hepatology 2011;54:173-184.
-
(2011)
Hepatology
, vol.54
, pp. 173-184
-
-
Tyson, G.L.1
El-Serag, H.B.2
-
5
-
-
15744389434
-
Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study
-
Shaib YH, El-Serag HB, Davila JA, Morgan R, McGlynn KA. Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. Gastroenterology 2005;128:620-626.
-
(2005)
Gastroenterology
, vol.128
, pp. 620-626
-
-
Shaib, Y.H.1
El-Serag, H.B.2
Davila, J.A.3
Morgan, R.4
McGlynn, K.A.5
-
6
-
-
33845792859
-
Risk factors for intrahepatic cholangiocarcinoma in a low-risk population: a nationwide case-control study
-
Welzel TM, Mellemkjaer L, Gloria G, Sakoda LC, Hsing AW, El Ghormli L, et al. Risk factors for intrahepatic cholangiocarcinoma in a low-risk population: a nationwide case-control study. Int J Cancer 2007;120:638-641.
-
(2007)
Int J Cancer
, vol.120
, pp. 638-641
-
-
Welzel, T.M.1
Mellemkjaer, L.2
Gloria, G.3
Sakoda, L.C.4
Hsing, A.W.5
El Ghormli, L.6
-
7
-
-
34247854758
-
Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study
-
Shaib YH, El-Serag HB, Nooka AK, Thomas M, Brown TD, Patt YZ, et al. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study. Am J Gastroenterol 2007;102:1016-1021.
-
(2007)
Am J Gastroenterol
, vol.102
, pp. 1016-1021
-
-
Shaib, Y.H.1
El-Serag, H.B.2
Nooka, A.K.3
Thomas, M.4
Brown, T.D.5
Patt, Y.Z.6
-
8
-
-
33745275877
-
Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States
-
Welzel TM, McGlynn KA, Hsing AW, O'Brien TR, Pfeiffer RM. Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States. J Natl Cancer Inst 2006;98:873-875.
-
(2006)
J Natl Cancer Inst
, vol.98
, pp. 873-875
-
-
Welzel, T.M.1
McGlynn, K.A.2
Hsing, A.W.3
O'Brien, T.R.4
Pfeiffer, R.M.5
-
9
-
-
78650215449
-
Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials
-
Rothwell PM, Wilson M, Elwin CE, Norrving B, Algra A, Warlow CP, et al. Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet 2010;376:1741-1750.
-
(2010)
Lancet
, vol.376
, pp. 1741-1750
-
-
Rothwell, P.M.1
Wilson, M.2
Elwin, C.E.3
Norrving, B.4
Algra, A.5
Warlow, C.P.6
-
10
-
-
78650825618
-
Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials
-
Rothwell PM, Fowkes FG, Belch JF, Ogawa H, Warlow CP, Meade TW. Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet 2011;377:31-41.
-
(2011)
Lancet
, vol.377
, pp. 31-41
-
-
Rothwell, P.M.1
Fowkes, F.G.2
Belch, J.F.3
Ogawa, H.4
Warlow, C.P.5
Meade, T.W.6
-
11
-
-
0032556188
-
Cyclooxygenase-2 inhibitors in tumorigenesis (part I)
-
Taketo MM. Cyclooxygenase-2 inhibitors in tumorigenesis (part I). J Natl Cancer Inst 1998;90:1529-1536.
-
(1998)
J Natl Cancer Inst
, vol.90
, pp. 1529-1536
-
-
Taketo, M.M.1
-
12
-
-
64049106907
-
Aspirin, salicylates, and cancer
-
Elwood PC, Gallagher AM, Duthie GG, Mur LA, Morgan G. Aspirin, salicylates, and cancer. Lancet 2009;373:1301-1309.
-
(2009)
Lancet
, vol.373
, pp. 1301-1309
-
-
Elwood, P.C.1
Gallagher, A.M.2
Duthie, G.G.3
Mur, L.A.4
Morgan, G.5
-
13
-
-
84873308604
-
Risk factors for intrahepatic cholangiocarcinoma: association between metformin use and reduced cancer risk
-
Chaiteerakij R, Yang JD, Harmsen WS, Slettedahl SW, Mettler TA, Fredericksen ZS, et al. Risk factors for intrahepatic cholangiocarcinoma: association between metformin use and reduced cancer risk. Hepatology 2013;57:648-655.
-
(2013)
Hepatology
, vol.57
, pp. 648-655
-
-
Chaiteerakij, R.1
Yang, J.D.2
Harmsen, W.S.3
Slettedahl, S.W.4
Mettler, T.A.5
Fredericksen, Z.S.6
-
14
-
-
84884648409
-
The Mayo Clinic Biobank: a building block for individualized medicine
-
Olson JE, Ryu E, Johnson KJ, Koenig BA, Maschke KJ, Morrisette JA, et al. The Mayo Clinic Biobank: a building block for individualized medicine. Mayo Clin Proc 2013;88:952-962.
-
(2013)
Mayo Clin Proc
, vol.88
, pp. 952-962
-
-
Olson, J.E.1
Ryu, E.2
Johnson, K.J.3
Koenig, B.A.4
Maschke, K.J.5
Morrisette, J.A.6
-
15
-
-
21244434022
-
2 promotes human cholangiocarcinoma cell growth and invasion through EP1 receptor-mediated activation of the epidermal growth factor receptor and Akt
-
2 promotes human cholangiocarcinoma cell growth and invasion through EP1 receptor-mediated activation of the epidermal growth factor receptor and Akt. J Biol Chem 2005;280:24053-24063.
-
(2005)
J Biol Chem
, vol.280
, pp. 24053-24063
-
-
Han, C.1
Wu, T.2
-
16
-
-
75349112988
-
Effects of selective COX-inhibitors and classical NSAIDs on endothelial cell proliferation and migration induced by human cholangiocarcinoma cell culture
-
Boonmasawai S, Akarasereenont P, Techatraisak K, Thaworn A, Chotewuttakorn S, Palo T. Effects of selective COX-inhibitors and classical NSAIDs on endothelial cell proliferation and migration induced by human cholangiocarcinoma cell culture. J Med Assoc Thai 2009;92:1508-1515.
-
(2009)
J Med Assoc Thai
, vol.92
, pp. 1508-1515
-
-
Boonmasawai, S.1
Akarasereenont, P.2
Techatraisak, K.3
Thaworn, A.4
Chotewuttakorn, S.5
Palo, T.6
-
17
-
-
0035032319
-
Biliary cancer growth factor pathways, cyclo-oxygenase-2 and potential therapeutic strategies
-
Sirica AE, Lai GH, Zhang Z. Biliary cancer growth factor pathways, cyclo-oxygenase-2 and potential therapeutic strategies. J Gastroenterol Hepatol 2001;16:363-372.
-
(2001)
J Gastroenterol Hepatol
, vol.16
, pp. 363-372
-
-
Sirica, A.E.1
Lai, G.H.2
Zhang, Z.3
-
18
-
-
0034802512
-
Differential expression of cyclooxygenase-2 (COX-2) in human bile duct epithelial cells and bile duct neoplasm
-
Hayashi N, Yamamoto H, Hiraoka N, Dono K, Ito Y, Okami J, et al. Differential expression of cyclooxygenase-2 (COX-2) in human bile duct epithelial cells and bile duct neoplasm. Hepatology 2001;34:638-650.
-
(2001)
Hepatology
, vol.34
, pp. 638-650
-
-
Hayashi, N.1
Yamamoto, H.2
Hiraoka, N.3
Dono, K.4
Ito, Y.5
Okami, J.6
-
19
-
-
37349041679
-
Aspirin dose and duration of use and risk of colorectal cancer in men
-
Chan AT, Giovannucci EL, Meyerhardt JA, Schernhammer ES, Wu K, Fuchs CS. Aspirin dose and duration of use and risk of colorectal cancer in men. Gastroenterology 2008;134:21-28.
-
(2008)
Gastroenterology
, vol.134
, pp. 21-28
-
-
Chan, A.T.1
Giovannucci, E.L.2
Meyerhardt, J.A.3
Schernhammer, E.S.4
Wu, K.5
Fuchs, C.S.6
-
20
-
-
84924043490
-
WNT signaling drives cholangiocarcinoma growth and can be pharmacologically inhibited
-
Boulter L, Guest RV, Kendall TJ, Wilson DH, Wojtacha D, Robson AJ, et al. WNT signaling drives cholangiocarcinoma growth and can be pharmacologically inhibited. J Clin Invest 2015;125:1269-1285.
-
(2015)
J Clin Invest
, vol.125
, pp. 1269-1285
-
-
Boulter, L.1
Guest, R.V.2
Kendall, T.J.3
Wilson, D.H.4
Wojtacha, D.5
Robson, A.J.6
-
21
-
-
84927623385
-
Molecular pathways: aspirin and Wnt signaling—a molecularly targeted approach to cancer prevention and treatment
-
Gala MK, Chan AT. Molecular pathways: aspirin and Wnt signaling—a molecularly targeted approach to cancer prevention and treatment. Clin Cancer Res 2015;21:1543-1548.
-
(2015)
Clin Cancer Res
, vol.21
, pp. 1543-1548
-
-
Gala, M.K.1
Chan, A.T.2
-
22
-
-
0141919448
-
Genomic instability and cancer
-
Charames GS, Bapat B. Genomic instability and cancer. Curr Mol Med 2003;3:589-596.
-
(2003)
Curr Mol Med
, vol.3
, pp. 589-596
-
-
Charames, G.S.1
Bapat, B.2
-
23
-
-
84903544426
-
Aspirin may prevent cholangiocarcinoma: a case-control study from the United Kingdom
-
Burr NE, Talboys RJ, Savva S, Clark A, Phillips M, Metcalfe M, et al. Aspirin may prevent cholangiocarcinoma: a case-control study from the United Kingdom. Dig Dis Sci 2014;59:1567-1572.
-
(2014)
Dig Dis Sci
, vol.59
, pp. 1567-1572
-
-
Burr, N.E.1
Talboys, R.J.2
Savva, S.3
Clark, A.4
Phillips, M.5
Metcalfe, M.6
-
24
-
-
20844445099
-
Aspirin use and risk of biliary tract cancer: a population-based study in Shanghai, China
-
Liu E, Sakoda LC, Gao YT, Rashid A, Shen MC, Wang BS, et al. Aspirin use and risk of biliary tract cancer: a population-based study in Shanghai, China. Cancer Epidemiol Biomarkers Prev 2005;14:1315-1318.
-
(2005)
Cancer Epidemiol Biomarkers Prev
, vol.14
, pp. 1315-1318
-
-
Liu, E.1
Sakoda, L.C.2
Gao, Y.T.3
Rashid, A.4
Shen, M.C.5
Wang, B.S.6
-
25
-
-
34247535910
-
Aspirin use among adults aged 40 and older in the United States: results of a national survey
-
Pignone M, Anderson GK, Binns K, Tilson HH, Weisman SM. Aspirin use among adults aged 40 and older in the United States: results of a national survey. Am J Prev Med 2007;32:403-407.
-
(2007)
Am J Prev Med
, vol.32
, pp. 403-407
-
-
Pignone, M.1
Anderson, G.K.2
Binns, K.3
Tilson, H.H.4
Weisman, S.M.5
-
26
-
-
84928258837
-
Aspirin use among adults in the U.S.: results of a national survey
-
Williams CD, Chan AT, Elman MR, Kristensen AH, Miser WF, Pignone MP, et al. Aspirin use among adults in the U.S.: results of a national survey. Am J Prev Med 2015;48:501-508.
-
(2015)
Am J Prev Med
, vol.48
, pp. 501-508
-
-
Williams, C.D.1
Chan, A.T.2
Elman, M.R.3
Kristensen, A.H.4
Miser, W.F.5
Pignone, M.P.6
-
27
-
-
21444450527
-
Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial
-
Cook NR, Lee IM, Gaziano JM, Gordon D, Ridker PM, Manson JE, et al. Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial. JAMA 2005;294:47-55.
-
(2005)
JAMA
, vol.294
, pp. 47-55
-
-
Cook, N.R.1
Lee, I.M.2
Gaziano, J.M.3
Gordon, D.4
Ridker, P.M.5
Manson, J.E.6
-
28
-
-
34248157118
-
Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies
-
Flossmann E, Rothwell PM. Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies. Lancet 2007;369:1603-1613.
-
(2007)
Lancet
, vol.369
, pp. 1603-1613
-
-
Flossmann, E.1
Rothwell, P.M.2
-
29
-
-
79951576682
-
Time-window bias in case-control studies: statins and lung cancer
-
Suissa S, Dell'aniello S, Vahey S, Renoux C. Time-window bias in case-control studies: statins and lung cancer. Epidemiology 2011;22:228-231.
-
(2011)
Epidemiology
, vol.22
, pp. 228-231
-
-
Suissa, S.1
Dell'aniello, S.2
Vahey, S.3
Renoux, C.4
-
30
-
-
58149250411
-
The antecedents of biliary cancer: a primary care case-control study in the United Kingdom
-
Grainge MJ, West J, Solaymani-Dodaran M, Aithal GP, Card TR. The antecedents of biliary cancer: a primary care case-control study in the United Kingdom. Br J Cancer 2009;100:178-180.
-
(2009)
Br J Cancer
, vol.100
, pp. 178-180
-
-
Grainge, M.J.1
West, J.2
Solaymani-Dodaran, M.3
Aithal, G.P.4
Card, T.R.5
-
31
-
-
84855534328
-
The influence of UGT1A6 variants and aspirin use in a randomized trial of celecoxib for prevention of colorectal adenoma
-
Chan AT, Hsu M, Zauber AG, Hawk ET, Bertagnolli MM. The influence of UGT1A6 variants and aspirin use in a randomized trial of celecoxib for prevention of colorectal adenoma. Cancer Prev Res (Phila) 2012;5:61-72.
-
(2012)
Cancer Prev Res (Phila)
, vol.5
, pp. 61-72
-
-
Chan, A.T.1
Hsu, M.2
Zauber, A.G.3
Hawk, E.T.4
Bertagnolli, M.M.5
-
32
-
-
84929390853
-
Association of aspirin and NSAID use with risk of colorectal cancer according to genetic variants
-
Nan H, Hutter CM, Lin Y, Jacobs EJ, Ulrich CM, White E, et al. Association of aspirin and NSAID use with risk of colorectal cancer according to genetic variants. JAMA 2015;313:1133-1142.
-
(2015)
JAMA
, vol.313
, pp. 1133-1142
-
-
Nan, H.1
Hutter, C.M.2
Lin, Y.3
Jacobs, E.J.4
Ulrich, C.M.5
White, E.6
|